Second, if you are still in the titration phase (the first 16-20 weeks), your dose may not yet be high enough to produce significant weight loss
It is contraindicated for use in patients with a personal or family history of medullary thyroid carcinoma and in those with multiple endocrine neoplasia type 2
22 This financial exclusion disproportionately impacts Black Americans, who are more likely to be uninsured or underinsured and face greater economic barriers to care
The FDA does not test these individual products for safety and efficacy
However, Foundayo may be a suitable option for patients who prefer a tablet over injections, those who have difficulty with self-injection or those looking to maintain weight loss achieved through injectable treatment
Healthy fats may contribute to meal-stimulated GLP-1 responses, though evidence for specific fat types (like omega-3 fatty acids and monounsaturated fats) having direct GLP-1 effects is mixed and modest